Analysis of cytokine functions in graft rejection by gene expression profiles

Transplantation

Volumn 76, Issue 12, 2003, Pages 1749-1758

  Liang, Yurong ^a   Christopher, Kenneth ^a   Defina, Rachel ^a   Cidado, Justin ^a   He, Hongzhen ^a   Haley, Kathleen J ^a   Finn, Patricia W ^a   Perkins, David L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CYTOKINE; GAMMA INTERFERON; GENE PRODUCT; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN F4 80; STAT4 PROTEIN; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ALGORITHM; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RIBONUCLEASE PROTECTION ASSAY; TH1 CELL; TH2 CELL; TRANSPLANTATION TOLERANCE;

ANALYSIS OF VARIANCE; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT SURVIVAL; INTERFERON TYPE II; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; STAT4 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TH1 CELLS; TH2 CELLS; TIME FACTORS; TRANS-ACTIVATORS; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0346102446     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000093464.72920.7C     Document Type: Article

References (30)

1. Nickerson P, Zheng XX, Steiger J, et al. Prolonged islet allograft acceptance in the absence of expression of interleukin-4. Adv Nephrol Necker Hosp 1997; 26: 171.
2. Bayer AL, Baliga P, Woodward JE. Transferrin receptor in T cell activation and transplantation. J Leukoc Biol 1998; 64(1): 19.
3. Bagley J, Sawada T, Wu Y, et al. A critical role for interleukin 4 in activating alloreactive CD4 T cells. Nat Immunol 2000; 1(3): 257.
4. Barbara JA, Turvey SE, Kingsley CI, et al. Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype. Transplantation 2000; 70(11): 1641.
5. Cua DJ, Coffman RL, Stohlman SA. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function. J Immunol 1996; 157(7): 2830.
6. Zheng XX, Steele AW, Nickerson PW, et al. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol 1995; 154(10): 5590.
7. Warle MC, Farhan A, Metselaar HJ, et al. In vitro cytokine production of TNFalpha and IL-13 correlates with acute liver transplant rejection. Hum Immunol 2001; 62(11): 1258.
8. Miura M, Morita K, Kobayashi H, et al. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 2001; 167(6): 3494.
9. Nagano H, Mitchell RN, Taylor MK et al. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997; 100(3): 550.
10. Konieczny BT, Dai Z, Elwood ET, et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160(5): 2059.
11. Halloran PF, Afrouzian M, Ramassar V, et al. Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol 2001; 158(1): 215.
12. Halloran PF, Miller LW, Urmson J, et al. IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol 2001; 166(12): 7072.
13. Morinobu A, Gadina M, Strober W, et al. STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci U S A 2002; 99(19): 12281.
14. Schmidt-Weber CB, Rao A, Lichtman AH. Integration of TCR and IL-4 signals through STAT6 and the regulation of IL-4 gene expression. Mol Immunol 2000; 37: 767.
15. Woodward JE, Bayer AL, Baliga P. Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor. Transplantation 1999; 68(9): 1369.
16. Arai K, Sunamura M, Wada Y, et al. Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection. Int J Pancreatol 1999; 26(1): 23.
17. Hallensleben W, Biro L, Sauder C, et al. A polymorphism in the mouse crg-2/IP-10 gene complicates chemokine gene expression analysis using a commercial ribonuclease protection assay. J Immunol Methods 2000; 234: 149.
18. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95(25): 14863.
19. Tamayo P, Slonim D, Mesirov J, et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A 1999; 96(6): 2907.
20. He H, Stone JR, Perkins DL. Analysis of robust innate immune response after transplantation in the absence of adaptive immunity. Transplantation 2002; 73(6): 853.
21. Murphy KM, Ouyang W, Szabo SJ, et al. T helper differentiation proceeds through Stat1-dependent, Stat4-dependent and Stat4-independent phases. Curr Top Microbiol Immunol 1999; 238: 13.
22. Pelletier RP, Morgan CJ, Sedmak DD, et al. Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts. Transplantation 1993; 55(2): 315.
23. Saiura A, Mataki C, Murakami T, et al. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 2001; 72(2): 320.
24. Saiura A, Kohro T, Yamamoto T, et al. Detection of an up-regulation of a group of chemokine genes in murine cardiac allograft in the absence of interferon-gamma by means of DNA microarray. Transplantation 2002; 73(9): 1480.
25. Dai Z, Lakkis FG. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection. Curr Opin Immunol 1999; 11(5): 504.
26. Zhou P, Szot GL, Guo Z, et al. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol 2000; 165(10): 5580.
27. Sho M, Yamada A, Najafian N, et al. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size. J Immunol 2002; 169(7): 3744.
28. Li XC, Roy-Chaudhury P, Hancock WW, et al. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J Immunol 1998; 161(2): 890.
29. Zand MS, Li Y, Hancock W, et al. Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts. Transplantation 2000; 70(9): 1378.
30. Orosz CG, VanBuskirk AM. Immune mechanisms of acute rejection. Transplant Proc 1998; 30(3): 859.